(Q33382537)

English

Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

B D Kahan

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

10 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S17-20

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

France and the early history of organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to Cyclosporine-based immunosuppressive regimens in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Median effect analysis of efficacy versus adverse effects of immunosuppressants

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Addressing the challenges for improving long-term outcomes in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Sirolimus permits steroid withdrawal from a cyclosporine regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.10.019

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2008.10.019

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33382537&oldid=1578325488"